Chemistry:Tirilazad
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Other names | (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C38H52N6O2 |
Molar mass | 624.874 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Tirilazad is a drug that has been proposed to treat acute ischaemic stroke. When tested on animal models, tirilazad protects brain tissue, and reduces brain damage. However, the drug fails to treat, and even worsens a stroke when studied on a human being.[1]
References
- ↑ "Tirilazad for acute ischaemic stroke". The Cochrane Database of Systematic Reviews (4): CD002087. 2001. doi:10.1002/14651858.CD002087. PMID 11687138.
Original source: https://en.wikipedia.org/wiki/Tirilazad.
Read more |